These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27351871)

  • 1. The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.
    Morio R; Hyogo H; Hatooka M; Morio K; Kan H; Kobayashi T; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Masayasu Y; Chayama K
    J Gastroenterol; 2017 Feb; 52(2):253-262. PubMed ID: 27351871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.
    Oki Y; Ono M; Hyogo H; Ochi T; Munekage K; Nozaki Y; Hirose A; Masuda K; Mizuta H; Okamoto N; Saibara T
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):797-805. PubMed ID: 29634665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease.
    Manchanayake J; Chitturi S; Nolan C; Farrell GC
    J Gastroenterol Hepatol; 2011 Mar; 26(3):510-6. PubMed ID: 21155882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy.
    Khaleeli AA; Johnson JN; Taylor WH
    Diabetes Metab Res Rev; 2007 Jan; 23(1):43-8. PubMed ID: 16703622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms for increased risk of diabetes in chronic liver diseases.
    Svegliati-Baroni G; Gaggini M; Carli F; Barbieri C; Cucco M; Youne R; Rosso C; Bugianesi E; Gastaldelli A
    Liver Int; 2020 Oct; 40(10):2489-2499. PubMed ID: 32515880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Different prevalence of impaired glucose tolerance between hyperinsulinemic and normoinsulinemic subjects].
    Xiao J; Tian H; Li CL; Zhong WW; Sun BR; Li YP; Fang FS; Han XF; Liu YQ; Cheng XL
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):299-303. PubMed ID: 22781951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.
    Miyake T; Kumagi T; Hirooka M; Furukawa S; Yoshida O; Koizumi M; Yamamoto S; Watanabe T; Yamamoto Y; Tokumoto Y; Takeshita E; Abe M; Kitai K; Matsuura B; Hiasa Y
    J Gastroenterol; 2016 Nov; 51(11):1090-1100. PubMed ID: 26971094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.
    Enooku K; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Tsutsumi T; Nakagomi R; Minami T; Sato M; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Fukayama M; Koike K
    J Gastroenterol; 2018 Dec; 53(12):1261-1275. PubMed ID: 29749571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical characteristics and trend of conversion to type 2 diabetes mellitus of individuals with normal glucose tolerance-hyperinsulinemia].
    Fang FS; Tian H; Li CL; Shao YH; Li J; Zhong WW; Liu MY; Yan ST; Yang G; Cheng XL; Ma Q; Wang HX
    Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):480-3. PubMed ID: 20979733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
    Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for regression from impaired glucose tolerance to normal glucose regulation in Japanese patients with nonalcoholic fatty liver disease.
    Ogata C; Ohmoto-Sekine Y; Tanabe M; Iwao A; Hsieh SD; Amakawa K; Matsumoto N; Ogawa K; Arimoto S; Okuda C; Shiba M; Kato H; Hashimoto M; Ishihara M; Tsuji H; Hara S; Arase Y
    Intern Med; 2014; 53(13):1401-6. PubMed ID: 24990331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.
    Junker AE; Gluud L; Holst JJ; Knop FK; Vilsbøll T
    J Intern Med; 2016 May; 279(5):485-93. PubMed ID: 26728692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2009 Apr; 29(4):525-9. PubMed ID: 19323780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone.
    Chai SY; Pan XY; Song KX; Huang YY; Li F; Cheng XY; Qu S
    Lipids Health Dis; 2014 Jan; 13():7. PubMed ID: 24397589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus.
    Kimura Y; Hyogo H; Ishitobi T; Nabeshima Y; Arihiro K; Chayama K
    J Gastroenterol Hepatol; 2011 Mar; 26(3):517-22. PubMed ID: 21054523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression from impaired glucose tolerance to type 2 diabetes in obese children and adolescents: a 3-6-year cohort study in southern Thailand.
    Jaruratanasirikul S; Thammaratchuchai S; Puwanant M; Mo-Suwan L; Sriplung H
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1267-1275. PubMed ID: 27740930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.